Steven Rowe
University of Texas Southwestern Medical Center · University of Alabama at Birmingham · Johns Hopkins University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
8
all conditions, ClinicalTrials.gov
NIH grants tied to them
12
1 more share only the name and are not shown
Trial papers in pancreatic cancer
0
PubMed author-name match
Trials
Studies that name Steven Rowe as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:09 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07432633 · [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology IndicationsBlue Earth Diagnostics · recruiting · Colorectal Cancer, Epithelial Ovarian Cancer, Gastric Cancer · principal investigator
- N/ANCT04613128 · The PROMISE Pediatric Study 6 to 11 Years OldNicole Hamblett · completed · Cystic Fibrosis, Cystic Fibrosis in Children · principal investigator
- Ph1NCT04528199 · [18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · Metastatic Prostate Cancer · principal investigator
- N/ANCT04038047 · A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR FunctionNicole Hamblett · completed · Cystic Fibrosis · principal investigator
- Ph1NCT03793543 · Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Prostate Cancer · principal investigator
- Ph1NCT03542773 · Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PETSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Schwannomas, Malignant Tumors · principal investigator
- N/ANCT02856100 · Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Prostate Cancer · principal investigator
- Ph2NCT02443688 · EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) PatientsCeltaxsys, Inc. · completed · Cystic Fibrosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical translation of a PD-L1 PET tracer to optimize immune checkpoint therapy in patients with non-small cell lung cancersR01CA269235 · NCI · JOHNS HOPKINS UNIVERSITY · fiscal years 2022 to 2026 · $620,981 awarded in 2026Same name and institution; not confirmed by an ID
- UAB CFRC Core C: Clinical and Translational CoreP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2012 to 2026 · $151,959 awarded in 2026Same name and institution; not confirmed by an ID
- Therapeutic targeting of MUC5B in a novel ferret model of idiopathic pulmonary fibrosisU01HL152978 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2021 to 2024 · $564,741 awarded in 2024Same name and institution; not confirmed by an ID
- Translational Program in CFTR-Related Airway DiseasesR35HL135816 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2017 to 2022 · $917,966 awarded in 2022Same name and institution; not confirmed by an ID
- UAB U-SPECT6CTUHROI ImagerS10OD030465 · OD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2021 · $750,000 awarded in 2021Same name and institution; not confirmed by an ID
- A Pilot Study of the Effect of the CFTR Potentiator Ivacaftor in COPD (P-TOPIC)R34HL127166 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2015 to 2016 · $303,126 awarded in 2016Same name and institution; not confirmed by an ID
- Molecular Pathogenesis and Phenotype of Acquired CFTR Dysfunction in COPDR01HL105487 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2011 to 2016 · $763,219 awarded in 2016Same name and institution; not confirmed by an ID
- Functional Anatomic Imaging of CF Patients with Early Lung Disease Using microOCTR01HL116213 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2012 to 2015 · $498,330 awarded in 2015Same name and institution; not confirmed by an ID
- Clinical and Mechanistic Features of Premature Termination Codon SuppressionK23DK075788 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2006 to 2010 · $127,764 awarded in 2010Same name and institution; not confirmed by an ID
- Mechanistic Basis Underlying Protein Repair of CFTR Nonsense MutationsR03DK084110 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2009 to 2010 · $72,518 awarded in 2010Same name and institution; not confirmed by an ID
- GENDER, MENSTRUAL CYCLE AND SMOKING CUE REACTIVITYM01RR001070 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · fiscal years 2008 · $10,462 awarded in 2008Same name and institution; not confirmed by an ID
- N-ACETYLCYSTEINE AS TREATMENT IN COCAINE ADDICTIONF32DA018501 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · fiscal years 2004 · $47,296 awarded in 2004Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- MOLECULAR ONCOLOGY RESOURCEP50CA103175 · NCI · JOHNS HOPKINS UNIVERSITY · PI Venu Raman · fiscal years 2003 to 2015Named on NCT03542773
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in pancreatic cancer.